What is Belite Bio Inc ADR (BLTE) stock price today?

Belite Bio Inc ADR (BLTE) currently trades at $154.50 per share. The stock has a market capitalization of $6.17B and a P/E ratio of —x.

Is BLTE stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Belite Bio Inc ADR has a Smart Value Score of 20/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 1/9 and Altman Z-Score is —.

Is Belite Bio Inc ADR financially healthy?

Belite Bio Inc ADR's Piotroski F-Score is 1/9 (weak financial health). The Altman Z-Score of — places it in the —.

BLTE

Belite Bio Inc ADR

NASDAQ: BLTE · HEALTHCARE · BIOTECHNOLOGY

$154.50

-2.66% today

Updated 2026-04-29

Market cap

$6.17B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-2.32

Dividend yield

—

52W range

$56 – $200

Volume

0.2M

Market cap

$6.17B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-2.32

Dividend yield

—

52W range

$56 – $200

Volume

0.2M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.5

Quality

C+

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$211.50

+36.89%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

2 Strong Buy6 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Piotroski 1/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-10.56M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-12.65M	$-31.63M	$-36.14M	$-77.61M	$-25.32M
EPS	—	—	—	—	$-2.32
Free cash flow	$-11.85M	$-29.90M	$-29.39M	$-37.17M	$-10.56M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
BLTE	$6.17B	20	4.3	3.0	5.0	5.5	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Belite Bio Inc ADR trades at $154.50. Our Smart Value Score of 20/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score.

Frequently asked questions

What is Belite Bio Inc ADR's stock price?

Belite Bio Inc ADR (BLTE) trades at $154.50.

Is Belite Bio Inc ADR overvalued?

Smart Value Score 20/100 (Grade F, Strong Sell).

What is the price target of Belite Bio Inc ADR (BLTE)?

The analyst target price is $211.50, representing +36.9% upside from the current price of $154.50.

Piotroski F-Score?

1/9 — weak financial health.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-16.90%

Beta-1.22

50D MA$168.47

200D MA$124.21

Shares out0.04B

Float0.02B

Short ratio—

Avg volume0.2M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

BLTE vs LLY →BLTE vs JNJ →BLTE vs ABBV →Stock screener →